Anti-chemokine small molecule drugs: a promising future? - Wikidata - wikimedia - TriplyDB

Anti-chemokine small molecule drugs: a promising future?

Anti-chemokine small molecule drugs: a promising future?

http://www.wikidata.org/entity/Q37683772

about

The chemokine superfamily revisited A novel CXCL10-based GPI-anchored fusion protein as adjuvant in NK-based tumor therapy Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior Emerging concepts and approaches for chemokine-receptor drug discovery.Chemokine receptor oligomerization and allostery.The yin and yang of chemokine receptor activation.G protein signaling modulator-3: a leukocyte regulator of inflammation in health and disease Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation.Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in African green monkeys Therapeutic antibodies directed at G protein-coupled receptors Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes.Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis.CCR6 as a possible therapeutic target in psoriasis.Functional inhibition of chemokine receptor CCR2 by dicer-substrate-siRNA prevents pain development Anti-inflammatory Agents: Present and Future Patented biological approaches for the therapeutic modulation of the 37 kDa/67 kDa laminin receptor.Biological therapies in primary Sjögren's syndrome.The complex world of oligodendroglial differentiation inhibitors.Pharmacological modulation of chemokine receptor function.Targeting inflammation in cardiovascular diseases. still a neglected field?Future perspectives: should Th17 cells be considered as a possible therapeutic target in acute myeloid leukemia patients receiving allogeneic stem cell transplantation?Therapeutic potential of chemokine receptor antagonists for liver disease.The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics.Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents.Chemokines in CNS injury and repair.Progress in the discovery of CC chemokine receptor 2 antagonists, 2009 - 2012.Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.Chemokine receptors in psoriasis.Chemokine receptor modeling: an interdisciplinary approach to drug design.What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5).Elucidation of the CCR1- and CCR5-binding modes of MIP-1α by application of an NMR spectra reconstruction method to the transferred cross-saturation experiments The role of chemokines in acute liver injury.A Subset of Patients with Acute Myeloid Leukemia Has Leukemia Cells Characterized by Chemokine Responsiveness and Altered Expression of Transcriptional as well as Angiogenic Regulators Optimized dosing of a CCR2 antagonist for amplification of vaccine immunity.Evasin-displaying lactic acid bacteria bind different chemokines and neutralize CXCL8 production in Caco-2 cells.Novel challenges for the allergist.Small molecule CXCR3 antagonist NIBR2130 has only a limited impact on type 1 diabetes in a virus-induced mouse model.

P2860

Q26824492-F2E8143E-C3E7-4047-9B0C-F5E1B29E1165 Q27308798-AF1FFC31-FC71-4CAC-A92F-7D46BCC916A1 Q27694728-EE24E8F1-9A33-4A7B-AED6-9B7A90B5154E Q33763369-F471720D-C6B2-4521-BD64-8B6ADBC5B13C Q33810517-BBDE72E0-FAB7-43D6-98CD-02946684CA9D Q34060799-3492AAF9-699E-4097-A886-2B57735C8A0E Q34066497-F0BE5975-D196-4508-845B-19BD9E58BDFD Q34153125-EE9DF3CE-33E9-439A-B2C2-0346AD652A6E Q34290999-CFE60C40-80CE-468F-8878-7875BDF96705 Q34445135-7DB7B2DC-6E90-4E71-8E0D-B17F231DBE42 Q35550241-7449859F-9B1B-499D-A953-AB179FF92CF4 Q35849570-4274AFAE-6D17-48A2-98CD-0F06C5FB20A3 Q36194247-E9BB043B-6C45-46EF-8E7E-8BC14FA48DEE Q36606727-B04C7625-4601-42FE-A870-0835BBB3F310 Q36980670-A3D17FE1-6FF9-4CC3-90C9-33B96B9E78DA Q37115195-AEC2EA14-C091-4292-82F0-7AE5DCE42477 Q37118156-43EEFE52-3E9B-418D-B18F-CB8B0D2ABD89 Q37812614-7E12D8AA-C534-49EC-882D-1330BA206E22 Q37860347-4CB5DF2C-ED77-45D3-87FC-26CB03A5C817 Q37869047-6A9E0D5D-246F-4561-94CE-313537DBEED1 Q37893687-48C17AA0-30C8-4FE7-8D62-570465DFFA08 Q37925018-C67A31E3-825D-414E-B918-787C163587A2 Q37944472-F2EFBE68-74BE-46F0-9CA3-E92230128906 Q37960533-7EF0C102-3056-4D36-9485-C374627124C5 Q37989141-6E0FCDDD-B48F-46D8-95ED-8134DE74D193 Q37991389-AF50C710-F7DB-4144-86FB-EE5D2FEF9F7A Q38018862-D4AC1E40-C3D6-4A05-BD6C-37BFE091E172 Q38083321-75C3BADF-D227-496D-913F-4293779CFCB4 Q38114832-3784DCFD-1B48-4801-8800-C8DC41E1DB9D Q38144211-CD9E8D30-E7CC-4588-BE43-1D49D70F3513 Q38172960-D2F9FFCF-36C0-435B-8390-B0113DEAAC6A Q38680670-734EFCFD-946F-4880-B585-BA59B81D1FC8 Q38796479-3D9419C8-06E6-4DC2-9BE7-8ACC2582EC82 Q38827574-0F14A310-E369-4A98-BE13-A1BF37BEA4E5 Q42208932-368E64B3-4B5D-44E1-9FDE-3C71E6477608 Q42764236-6A0886B1-D8A9-4375-81B1-EDC28A734136 Q42771123-FF94EF2C-32B4-471F-AD73-FDFAC6A54672 Q43216438-5936E25C-9D48-4DB3-BA3C-F6CB35E376C6 Q45087012-7E0C2ECE-96D0-4579-BEB9-F98C08995DFA Q45365916-9616BD0C-8DF5-4D55-89C1-FE18F7613D76

P2860

Anti-chemokine small molecule drugs: a promising future?

http://www.wikidata.org/entity/Q37683772

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Anti-chemokine small molecule drugs: a promising future?

@en

Anti-chemokine small molecule drugs: a promising future?

@nl

type

label

Anti-chemokine small molecule drugs: a promising future?

@en

Anti-chemokine small molecule drugs: a promising future?

@nl

prefLabel

Anti-chemokine small molecule drugs: a promising future?

@en

Anti-chemokine small molecule drugs: a promising future?

@nl

P1433

Q37683772-EBC69438-7AED-4D27-ADC1-BCAD0A61727A

P1476

Q37683772-18FA7F18-0FF6-42B9-9F9F-79ABC5ABE5CE

P2093

Q37683772-7D433A30-5717-4507-B454-01CE6E3A363E

Q37683772-E1125727-8445-43FF-A509-83A9B8745F29

Q37683772-F00989A4-FED0-4C3F-BE80-B24CF0C7658A

P2860

Q37683772-008EFBEE-8C2D-4D18-AC0F-6D0F173E5B2A

Q37683772-026EFEEC-1AF0-461C-9A54-3635BB4A30EA

Q37683772-03D9E147-CFAF-4E0B-9E86-A4ABAC7C22FC

Q37683772-08C3E290-D94C-48F1-8305-7074F8E3812F

Q37683772-0C07D1A9-7EFE-4C1B-AAD3-E3EFDCDB5EB6

Q37683772-12DDFF8A-AAB6-4EC6-83D0-2B201164104F

Q37683772-142A89C1-CDF7-4230-BD88-6D109044C97B

Q37683772-1D51E68F-4796-469A-975C-96351BF9DA45

Q37683772-251E50D9-80DD-4262-86E8-8611C5D6B247

Q37683772-251F2D3D-673B-4C02-8B2A-FB2FEA425A79

P304

Q37683772-C217F56F-CC23-4B57-9068-0245C6BD52E1

P31

Q37683772-DA8DF5C1-44F9-4EAF-9B1E-6032A8CF4B9D

P356

Q37683772-AA308E9E-C0EA-4486-8762-91589A116782

P407

Q37683772-B094B67F-52E7-473A-8021-9BB3A2C7E946

P433

Q37683772-FAE91C26-777A-47DF-B888-488D247502FC

P478

Q37683772-A48C63AE-5675-4B35-AD44-F3A26CCC4021

P577

Q37683772-AFCD230F-100C-4152-B508-C8538840A35E

P698

Q37683772-F703E47E-99CC-4647-A445-6B2CF497FE73

P356

13543780903535867

P1433

Expert Opinion on Investigational Drugs

P1476

Anti-chemokine small molecule drugs: a promising future?

@en

P2093

Amanda E I Proudfoot

http://www.w3.org/2001/XMLSchema#string

Christine A Power

http://www.w3.org/2001/XMLSchema#string

Matthias K Schwarz

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes

Molecular cloning and functional expression of a new human CC-chemokine receptor gene

Structure and functional expression of a human interleukin-8 receptor

Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients

Hepatotoxicity observed in clinical trials of aplaviroc (GW873140)

Structure and functional expression of the human macrophage inflammatory protein 1 alpha/RANTES receptor

Chemokines and disease

Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor

P304

345-355

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543780903535867

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20113217

http://www.w3.org/2001/XMLSchema#string